Discovery of novel isoflavone derivatives as AChE/BuChE dual-targeted inhibitors: synthesis, biological evaluation and molecular modelling
AChE and BuChE are druggable targets for the discovery of anti-Alzheimer's disease drugs, while dual-inhibition of these two targets seems to be more effective. In this study, we synthesised a series of novel isoflavone derivatives based on our hit compound G from in silico high-throughput scre...
Saved in:
Main Authors: | Bo Feng (Author), Xinpeng Li (Author), Jie Xia (Author), Song Wu (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2017-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A hybrid of 1-deoxynojirimycin and benzotriazole induces preferential inhibition of butyrylcholinesterase (BuChE) over acetylcholinesterase (AChE)
by: Tereza Cristina Santos Evangelista, et al.
Published: (2022) -
Tertiary amine derivatives of chlorochalcone as acetylcholinesterase (AChE) and buthylcholinesterase (BuChE) inhibitors: the influence of chlorine, alkyl amine side chain and α,β-unsaturated ketone group
by: Xiao-hui Gao, et al.
Published: (2017) -
Computational and ADMET Predictions of Novel Compounds as Dual Inhibitors of BuChE and GSK-3β to Combat Alzheimer's Disease
by: Saurabh G. Londhe, et al.
Published: (2024) -
Tuning the activity of iminosugars: novel N-alkylated deoxynojirimycin derivatives as strong BuChE inhibitors
by: Ana I. Ahuja-Casarín, et al.
Published: (2021) -
Quetiapine and novel PDE10A inhibitors potentiate the anti-BuChE activity of donepezil
by: Joanna Sikora, et al.
Published: (2020)